The growing number of individuals with disabilities, particularly those experiencing severe and moderate impairments, is expected to drive an increased need for adult incontinence products in Estonia. With 36% of people with disabilities classified as having severe impairments and 53% with moderate impairments, the demographic shift towards a larger population requiring specialized care solutions will likely spur higher demand for Rx/reimbursement of adult incontinence products.
During the forecast period, a notable uptick in public funding for essential care services is anticipated, potentially expanding access to adult incontinence products. Additionally, the prevalence of diseases traditionally associated with ageing, such as dementia, Alzheimer's, or Parkinson's, is on the rise among younger age groups, particularly individuals aged 55 and above.
In the coming years, the ongoing evolution of nursing home reforms is poised to have significant implications for the adult incontinence market in Estonia. Since the implementation of these reforms, which have facilitated increased state support for nursing home placements, there has been a notable surge in demand for these services.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Estonia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Estonia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See All of Our DefinitionsThis report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!